pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

312 catalysts · 18,987 approval · 5,000 device 510k · 4,876 phase readout · 4,728 grant · 2,420 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 7 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: filing×type: patent expiry×clear all
type
  • approval18,987
  • device 510k5,000
  • phase readout4,876
  • grant4,728
  • 8k filing2,420
  • device pma2,000
device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings295
  • therapy area
    • Infectious Disease9
    • Ophthalmology5
    • Oncology2
    • Dermatology1
    • Pulmonology1

    Week of Feb 9, 2026

    2
    ›Feb 10, 2026earnings167d agoCSL LTD earningsCSL LTD

    Anticipated earnings call for CSL LTD ($CSLLY).

    full page →yahoo earnings ↗
    ›Feb 13, 2026earnings164d agoBeyond Air, Inc. earningsBeyond Air, Inc.

    Anticipated earnings call for Beyond Air, Inc. ($XAIR).

    full page →yahoo earnings ↗

    Week of Feb 23, 2026

    2
    ›Feb 25, 2026earnings152d agoHaleon plc earningsHaleon plc

    Anticipated earnings call for Haleon plc ($HLN).

    full page →yahoo earnings ↗
    ›Feb 26, 2026earnings

    Week of Mar 2, 2026

    1
    ›Mar 2, 2026earnings147d agoSMITH & NEPHEW PLC earningsSMITH & NEPHEW PLC

    Anticipated earnings call for SMITH & NEPHEW PLC ($SNN).

    full page →yahoo earnings ↗

    Week of Mar 9, 2026

    1
    ›Mar 12, 2026earnings137d agoScilex Holding Co earningsScilex Holding Co

    Anticipated earnings call for Scilex Holding Co ($SCLX).

    full page →yahoo earnings ↗

    Week of Mar 23, 2026

    1
    ›Mar 26, 2026earnings123d agoBioXcel Therapeutics, Inc. earningsBioXcel Therapeutics, Inc.

    Anticipated earnings call for BioXcel Therapeutics, Inc. ($BTAI).

    full page →yahoo earnings ↗

    Week of Apr 20, 2026

    6
    ›Apr 23, 2026earnings95d agoACME UNITED CORP earningsACME UNITED CORP

    Anticipated earnings call for ACME UNITED CORP ($ACU).

    full page →yahoo earnings ↗
    ›Apr 23, 2026earnings

    Week of Apr 27, 2026

    37
    ›Apr 27, 2026patent expiry91d agoBill & Melinda Gates Medical Research Institute — SB-692342 (Constraining Patent Expiry (Japan))SB-692342

    Therapy area: Infectious Disease. Indication: Pulmonary Tuberculosis

    full page →SB-692342 →source: globaldata
    ›Apr 28, 2026patent expiry
    ← prev
    page 1 of 7
    next →
    151d ago
    Grifols SA earningsGrifols SA

    Anticipated earnings call for Grifols SA ($GRFS).

    full page →yahoo earnings ↗
    95d ago
    Sanofi earningsSanofi

    Anticipated earnings call for Sanofi ($SNY).

    full page →yahoo earnings ↗
    ›Apr 24, 2026patent expiry94d agoDaiichi Sankyo Co Ltd — laninamivir (Constraining Patent Expiry (Japan))laninamivir

    Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections

    full page →laninamivir →source: globaldata
    ›Apr 24, 2026patent expiry94d agoEisai Co Ltd — lenvatinib mesylate (Constraining Patent Expiry (US))lenvatinib mesylate

    Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S

    full page →lenvatinib mesylate →source: globaldata
    ›Apr 25, 2026patent expiry93d agoStemline Therapeutics Inc — SL-901 (Constraining Patent Expiry (Japan))SL-901

    Therapy area: Oncology, Undisclosed. Indication: Lung Cancer, Solid Tumor, Unspecified Rare Disease

    full page →SL-901 →source: globaldata
    ›Apr 26, 2026patent expiry92d agoBlue Blood Biotech Corp — BB-101 (Constraining Patent Expiry (Japan))BB-101

    Therapy area: Dermatology. Indication: Diabetic Foot Ulcers

    full page →BB-101 →source: globaldata
    90d ago
    GSK plc — dolutegravir sodium ODT (Constraining Patent Expiry (Japan))dolutegravir sodium

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →dolutegravir sodium →source: globaldata
    ›Apr 28, 2026patent expiry90d agoGSK plc — (abacavir sulfate + dolutegravir sodium+ lamivudine) ODT (Constraining Patent Expiry (Japan))(abacavir sulfate + dolutegravir sodium + lamivudine)

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →(abacavir sulfate + dolutegravir sodium + lamivudine) →source: globaldata
    ›Apr 28, 2026patent expiry90d agoGSK plc — cabotegravir sodium (Constraining Patent Expiry (US))cabotegravir sodium

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir sodium →source: globaldata
    ›Apr 28, 2026patent expiry90d agoViiV Healthcare UK Ltd — cabotegravir + rilpivirine LA (Constraining Patent Expiry (US))cabotegravir + rilpivirine LA

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir + rilpivirine LA →source: globaldata
    ›Apr 28, 2026patent expiry90d agoViiV Healthcare UK Ltd — cabotegravir LA (Constraining Patent Expiry (US))cabotegravir LA

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir LA →source: globaldata
    ›Apr 28, 2026earnings90d agoNOVARTIS AG earningsNOVARTIS AG

    Anticipated earnings call for NOVARTIS AG ($NVS).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings90d agoINCYTE CORP earningsINCYTE CORP

    Anticipated earnings call for INCYTE CORP ($INCY).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings90d agoECOLAB INC. earningsECOLAB INC.

    Anticipated earnings call for ECOLAB INC. ($ECL).

    full page →yahoo earnings ↗
    ›Apr 28, 2026earnings90d agoOrion Group Holdings Inc earningsOrion Group Holdings Inc

    Anticipated earnings call for Orion Group Holdings Inc ($ORN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoAbbVie Inc. earningsAbbVie Inc.

    Anticipated earnings call for AbbVie Inc. ($ABBV).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoASTRAZENECA PLC earningsASTRAZENECA PLC

    Anticipated earnings call for ASTRAZENECA PLC ($AZN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoGSK plc earningsGSK plc

    Anticipated earnings call for GSK plc ($GSK).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoREGENERON PHARMACEUTICALS, INC. earningsREGENERON PHARMACEUTICALS, INC.

    Anticipated earnings call for REGENERON PHARMACEUTICALS, INC. ($REGN).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoTEVA PHARMACEUTICAL INDUSTRIES LTD earningsTEVA PHARMACEUTICAL INDUSTRIES LTD

    Anticipated earnings call for TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoGLAUKOS Corp earningsGLAUKOS Corp

    Anticipated earnings call for GLAUKOS Corp ($GKOS).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoBIOGEN INC. earningsBIOGEN INC.

    Anticipated earnings call for BIOGEN INC. ($BIIB).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoBausch & Lomb Corp earningsBausch & Lomb Corp

    Anticipated earnings call for Bausch & Lomb Corp ($BLCO).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoSBA COMMUNICATIONS CORP earningsSBA COMMUNICATIONS CORP

    Anticipated earnings call for SBA COMMUNICATIONS CORP ($SBAC).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoAGIOS PHARMACEUTICALS, INC. earningsAGIOS PHARMACEUTICALS, INC.

    Anticipated earnings call for AGIOS PHARMACEUTICALS, INC. ($AGIO).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoIONIS PHARMACEUTICALS INC earningsIONIS PHARMACEUTICALS INC

    Anticipated earnings call for IONIS PHARMACEUTICALS INC ($IONS).

    full page →yahoo earnings ↗
    ›Apr 29, 2026earnings89d agoAvantor, Inc. earningsAvantor, Inc.

    Anticipated earnings call for Avantor, Inc. ($AVTR).

    full page →yahoo earnings ↗
    ›Apr 30, 2026patent expiry88d agoBasilea Pharmaceutica Ltd — isavuconazonium sulfate (Constraining Patent Expiry (US))isavuconazonium sulfate

    Therapy area: Infectious Disease. Indication: Aspergillosis, Candidiasis, Cryptococcal Meningitis, Cryptococcosis, Zygomycosis (Mucormycosis)

    full page →isavuconazonium sulfate →source: globaldata
    ›Apr 30, 2026filing88d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing88d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Choroidal Neovascularization

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing88d agoSarepta Therapeutics Inc — golodirsen (NDA/BLA Filing (US))golodirsen

    Therapy area: Genetic Disorders. Indication: Duchenne Muscular Dystrophy

    full page →golodirsen →source: globaldata
    ›Apr 30, 2026filing88d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Retinal Vein Occlusion

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing88d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Diabetic Retinopathy

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026filing88d agoXbrane Biopharma AB — ranibizumab biosimilar (NDA/BLA Filing (US))ranibizumab biosimilar

    Therapy area: Ophthalmology. Indication: Diabetic Macular Edema

    full page →ranibizumab biosimilar →source: globaldata
    ›Apr 30, 2026earnings88d agoMERIT MEDICAL SYSTEMS INC earningsMERIT MEDICAL SYSTEMS INC

    Anticipated earnings call for MERIT MEDICAL SYSTEMS INC ($MMSI).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoMerck & Co., Inc. earningsMerck & Co., Inc.

    Anticipated earnings call for Merck & Co., Inc. ($MRK).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoCARDINAL HEALTH INC earningsCARDINAL HEALTH INC

    Anticipated earnings call for CARDINAL HEALTH INC ($CAH).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoDEXCOM INC earningsDEXCOM INC

    Anticipated earnings call for DEXCOM INC ($DXCM).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoELI LILLY & Co earningsELI LILLY & Co

    Anticipated earnings call for ELI LILLY & Co ($LLY).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoSTRYKER CORP earningsSTRYKER CORP

    Anticipated earnings call for STRYKER CORP ($SYK).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoBRISTOL MYERS SQUIBB CO earningsBRISTOL MYERS SQUIBB CO

    Anticipated earnings call for BRISTOL MYERS SQUIBB CO ($BMY).

    full page →yahoo earnings ↗
    ›Apr 30, 2026earnings88d agoAMGEN INC earningsAMGEN INC

    Anticipated earnings call for AMGEN INC ($AMGN).

    full page →yahoo earnings ↗
    $CSLLY18.19-16.21%
    $SNN30.25+5.29%
    $HLN9.2000+0.33%
    $SCLX8.8000+25.00%
    $XAIR0.3798-1.61%
    $ACU45.90-1.54%
    $BTAI0.9215-10.53%
    $GRFS7.8400-0.38%
    $SNY43.35-0.02%
    $GSK51.35+1.20%
    $GSK51.35+1.20%
    $GSK51.35+1.20%
    $NVS155.01-0.72%
    $ECL268.75+2.13%
    $ORN12.69-1.78%
    $INCY117.67+0.84%
    $ABBV259.36+0.95%
    $AZN169.26+0.59%
    $GSK51.35+1.20%
    $REGN656.01+0.63%
    $TEVA30.81-1.19%
    $GKOS153.58+0.95%
    $BLCO16.17+1.19%
    $BIIB202.19+0.78%
    $SBAC173.57-0.73%
    $AGIO36.36+0.22%
    $AVTR11.44+0.79%
    $IONS56.55+1.22%
    $SRPT15.68-1.26%
    $MMSI74.32+1.66%
    $MRK131.07+0.45%
    $CAH228.03+0.91%
    $DXCM71.54+1.50%
    $BMY62.09+0.94%
    $LLY1196.03+0.86%
    $SYK330.25+3.54%
    $AMGN376.04+1.22%